Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothAcamprosate 333mg
Acamptas 333mg Tablet 6s
You Searched
Acamptas 333mg Tablet 6s
Intas Pharmaceuticals Ltd.
₹117
Our Recommendation
Acampure 333mg Tablet 6s
1,876+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Alcohol addiction
Customers also bought
More About Acamptas
Benefits
In Alcohol addiction Acamptas 333 Tablet is a medicine used, along with social support and counseling, to help people recover from alcohol addiction and to avoid having the urge to drink alcohol again. Acamptas 333 Tablet starts working from the very first dose and is a very safe and effective way of treating alcohol addiction.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Acamptas 333 Tablet is to be taken with food.
How it works
Acamprosate is believed to stabilize the chemical balance in the brain by blocking glutaminergic N-methyl-D-aspartate receptors and activating the gamma-aminobutyric acid type A receptors.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Acamptas 333 Tablet . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Acamptas 333 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Acamptas 333 Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
SAFE - Acamptas 333 Tablet does not usually affect your ability to drive.
Caution Advised: Acamptas 333 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Acamptas 333 Tablet may be needed. Doctor consultation is advised. Use of Acamptas 333 Tablet is not recommended in patients with severe kidney disease.
Caution Advised: Acamptas 333 Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Acamptas 333 Tablet may be needed. Doctor consultation is advised. Limited information is available on the use of Acamptas 333 Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
What if I forget to take it?
If a dose of Acamptas 333 Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.
References
Stahl SM, editor. Acamprosate. In: Stahl's Essential Psychopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 1-3
Schuckit MA. Ethanol and Methanol. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 643
Masters SB. The Alcohols. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 395
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 5-6
Acamprosate (24 Jan. 2019)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
Acamprosate calcium (03 Mar. 2025)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
